Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RAS”

567 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 567 results

Early research (Phase 1)Not Yet RecruitingNCT07836036
What this trial is testing

Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations

Who this might be right for
Solid TumorRAS Mutation
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 200
Not applicableStudy completedNCT02322736
What this trial is testing

Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORR

Who this might be right for
Metastatic Colorectal Cancer
Amgen 218
Early research (Phase 1)Ended earlyNCT07121829
What this trial is testing

Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorPilocytic Astrocytoma+7 more
Day One Biopharmaceuticals, Inc. 44
Not applicableStudy completedNCT01834014
What this trial is testing

Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases

Who this might be right for
Liver MetastasisColorectal Cancer
EPS Corporation 110
Early research (Phase 1)Ended earlyNCT06194877
What this trial is testing

Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers

Who this might be right for
Colorectal CancerPancreatic Ductal CancerAdvanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers
MapKure, LLC 13
Not applicableStudy completedNCT03228888
What this trial is testing

Effects of Ecological Rythmic-acoustic Stimulation (E-RAS) on Motor Skills in Individuals With Parkinson's Disease

Who this might be right for
Parkinson Disease
University of Cagliari 32
Not applicableUnknownNCT04647188
What this trial is testing

Measuring the Quality of Surgical Care and Setting Benchmarks for Training Using Intuitive Data Recorder Technology

Who this might be right for
CancerSurgery
University of Birmingham 500
Testing effectiveness (Phase 2)Study completedNCT05278728
What this trial is testing

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

Who this might be right for
Colorectal Cancer
Biotech Pharmaceutical Co., Ltd. 31
Large-scale testing (Phase 3)Study completedNCT00985322
What this trial is testing

Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis

Who this might be right for
Left Ventricular HypertrophyHypertension
Mario Negri Institute for Pharmacological Research 269
Not applicableUnknownNCT05051592
What this trial is testing

Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
National University Hospital, Singapore 40
Post-approval studies (Phase 4)Study completedNCT01723228
What this trial is testing

Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 170
Testing effectiveness (Phase 2)UnknownNCT01410214
What this trial is testing

Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations

Who this might be right for
Non-small Cell Lung Cancer Stage IIIA
Chinese Lung Cancer Surgical Group 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06835179
What this trial is testing

SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.

Who this might be right for
Unresectable Metastatic Colorectal CancerMicrosatellite Stable (MSS) Colorectal Cancer (CRC)RAS-mutant Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 28
Not applicableLooking for participantsNCT06449989
What this trial is testing

Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticBrain Metastases, AdultRas (KRAS or NRAS) Gene Mutation+3 more
Blokhin's Russian Cancer Research Center 30
Testing effectiveness (Phase 2)WithdrawnNCT02785068
What this trial is testing

Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Merrimack Pharmaceuticals
Post-approval studies (Phase 4)UnknownNCT00696215
What this trial is testing

The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Istanbul University 40
Post-approval studies (Phase 4)Study completedNCT04353596
What this trial is testing

Stopping ACE-inhibitors in COVID-19

Who this might be right for
SARS-CoV-2COVID-19
Medical University Innsbruck 216
Early research (Phase 1)WithdrawnNCT02630420
What this trial is testing

Cetuximab and Savolitinib Treatment of Ras Wild-Type Colorectal Cancer

Who this might be right for
Colorectal Cancer
Yale University
Large-scale testing (Phase 3)Active Not RecruitingNCT03635021
What this trial is testing

Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer

Who this might be right for
Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 419
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07198321
What this trial is testing

A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors

Who this might be right for
CancerPDACCRC (Colorectal Cancer)+1 more
Genfleet Therapeutics (Shanghai) Inc. 450
Next Page